Search

Jesica Swanstrom Phones & Addresses

  • 1301 Hemby Ridge Ln, Morrisville, NC 27560
  • Cary, NC
  • Holly Springs, NC
  • Greenville, NC

Resumes

Resumes

Jesica Swanstrom Photo 1

Jesica Swanstrom

View page
Location:
Morrisville, NC
Industry:
Higher Education
Jesica Swanstrom Photo 2

Research Specialist At Unc Hospital Immunology Core Facility

View page
Position:
Research Specialist at UNC Hospital Immunology Core Facility
Location:
Raleigh-Durham, North Carolina Area
Industry:
Biotechnology
Work:
UNC Hospital Immunology Core Facility since Apr 2008
Research Specialist
Education:
Peace College 2003 - 2007
Bachelors, Biology, Chemistry

Publications

Us Patents

Methods And Compositions For Zika Virus Vaccines

View page
US Patent:
20190023745, Jan 24, 2019
Filed:
Jul 19, 2018
Appl. No.:
16/040267
Inventors:
- Chapel Hill NC, US
Jessica A. Plante - Texas City TX, US
Jesica Swanstrom - Morrisville NC, US
Matthew Begley - Durham NC, US
International Classification:
C07K 14/005
C07K 16/10
A61P 31/14
Abstract:
The present invention methods and compositions for treating a Zika virus infection in a subject, comprising administering to the subject an effective amount of an antibody against Zika virus and/or an epitope that induces an immune response to Zika virus.

Methods And Compositions For Recombinant Dengue Viruses For Vaccine And Diagnostic Development

View page
US Patent:
20170333548, Nov 23, 2017
Filed:
Nov 2, 2015
Appl. No.:
15/523899
Inventors:
- Chapel Hill NC, US
Douglas Widman - Carrboro NC, US
Boyd Yount - Hillsborough NC, US
Emily Gallichotte - Carrboro NC, US
Scott Royal - Carrboro NC, US
Aravinda Desilva - Chapel Hill NC, US
Jesica Swanstrom - Morrisville NC, US
International Classification:
A61K 39/12
C12N 7/00
G01N 33/569
C07K 14/005
A61K 39/00
Abstract:
The present invention provides compositions and methods of use comprising a chimeric dengue virus E glycoprotein comprising a dengue virus E glycoprotein backbone, which comprises amino acid substitutions that introduce an epitope that is recognized by an antibody from a dengue virus serotype that is different from the dengue virus serotype of the dengue virus E glycoprotein backbone.

Methods And Compositions For Norovirus Blockade Epitopes

View page
US Patent:
20140271712, Sep 18, 2014
Filed:
Mar 14, 2014
Appl. No.:
14/213469
Inventors:
- Chapel Hill NC, US
Lisa Chon Lindesmith - Apex NC, US
Kari Moore Debbink - Durham NC, US
Eric Francis Donaldson - Durham NC, US
Jesica Anne Swanstrom - Morrisville NC, US
Assignee:
The University of North Carolina at Chapel Hill - Chapel Hill NC
International Classification:
C07K 14/005
G01N 33/569
US Classification:
4242161, 530350, 536 2372, 4353201, 435 5
Abstract:
The present invention provides methods and compositions comprising a chimeric norovirus capsid protein comprising a norovirus VP1 major capsid protein backbone comprising a norovirus epitope selected from the group consisting of: a) Epitope A; b) Epitope B; c) Epitope C; d) Epitope D; e) Epitope E; f) Epitope F; and g) any combination of (a) through (f) above, wherein the norovirus epitope is from a norovirus strain that is different from the norovirus VP1 major capsid protein backbone.
Jesica A Swanstrom from Morrisville, NC, age ~42 Get Report